Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...

Journal of Nuclear Medicine October 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278 ...

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands ...

Journal of Nuclear Medicine October 2024, jnumed.124.268033; DOI: https://doi.org/10.2967/jnumed.124.268033 ...

Journal of Nuclear Medicine October 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948 ...

Learning Objectives 1. Review techniques for RBC preparation and labelling. 2. Review imaging protocol and imaging findings. 3. Present examples where SPECT/CT helped with hemangioma ...

Journal of Nuclear Medicine September 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489 ...

Journal of Nuclear Medicine September 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151 ...

Objectives To measure the urinary excretion of Yttrium-90 (90Y) following intra-arterial (IA) treatment with 90Y-microspheres for liver tumours. Methods Urine was collected over 12h. 3 samples of 2 ml ...

S.J. McPhee, M.A. Papadakis, and L.M. Tierney, Jr., eds. New York, NY: McGraw Hill Medical, 2008, 1,673 pages, $69.95 Medicine is an ever-changing field, and changes in patient treatment are required ...

Journal of Nuclear Medicine October 2024, jnumed.124.267529; DOI: https://doi.org/10.2967/jnumed.124.267529 ...

Objectives Dementia with Lewy Bodies (DLB) is the second most frequent neuropathology after Alzheimer’s disease. Its diagnosis is based on clinical specific symptoms (Mc Keith’s criteria) including ...